Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 526-550 of 946 matching filings.

Per page
25
Current page
22
8-K File 001-36297

8-K

Filing date
15 Mar 2019
Reporting date
12 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-229977

S-8

Filing date
28 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
26 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2019
Reporting date
15 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Feb 2019
Reporting date
15 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88023

SC 13G filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SEC SCHEDULE 13G

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A filing

Filing date
06 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A filing

Filing date
29 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SC 13G/A filing

Filing date
28 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
25 Jan 2019
Reporting date
24 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Jan 2019
Reporting date
22 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
17 Jan 2019
Reporting date
16 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221911

424B5

Filing date
17 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
15 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221911

424B5

Filing date
15 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .